AI assistant
Sending…
Fulgent Genetics, Inc. — Director's Dealing 2019
Sep 17, 2019
32553_dirs_2019-09-16_2366d862-596d-4072-986f-dee7531de84b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-09-12
Reporting Person: Gao Hanlin (Chief Scientific Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-12 | Issuer Common Stock | J | 500000 | $0.00 | Disposed | 1267659 | Direct |
Footnotes
F1: The transfer was made without the receipt of consideration to a blind trust. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16 or for any other purpose.
More from Fulgent Genetics, Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 26